TABLE 2.

Association between baseline characteristics and drug resistance

Dependent variable	Adjusted OR (95% CI) a	p
Epilepsy latency b	0.21 (0.09–0.48)	<0.001
Cerebral hemorrhage	5.67 (1.84–17.49)	0.003
Severe stroke	4.10 (1.39–12.12)	0.011
Status epilepticus at epilepsy onset	6.41 (1.36–30.20)	0.019
Type of seizures c
Focal‐to‐bilateral tonic–clonic	1.71 (0.59–4.95)	0.324
Generalized/unknown onset	0.26 (0.03–2.53)	0.245

Note: Values are from binary logistic regression analysis.

Abbreviations: CI, confidence interval; OR, odds ratio.

^a Adjusted for length of latent period (log transformed), stroke type and severity, status epilepticus at epilepsy onset, and seizure type.

^b The latency of epilepsy was defined as the time interval (months) between stroke onset and the occurrence of first‐time unprovoked poststroke seizure.

^c Focal onset seizures as reference.